Ledger.Open graph →
SEC Form D · filed March 24, 2014

Sage Therapeutics, Inc

Offering
$38.0M
Sold
$38.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jeffery M. Jonas · Cambridge, MAExec · DirectorRobert T. Nelsen · Cambridge, MADirectorSteven T. Paul · Cambridge, MADirectorKevin T. Starr · Cambridge, MADirectorKimi M. Iguchi · Cambridge, MAExecLouis M. Bacon · New York, NYDirectorLawrence M. Noe · New York, NYDirectorDenise M. Jeffries · New York, NYDirectorScott M. Lawin · New York, NYExec · DirectorAnthony J. Deluca · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗